FR2306706A1 - Agent regulateur intestinal et procede d'obtention - Google Patents

Agent regulateur intestinal et procede d'obtention

Info

Publication number
FR2306706A1
FR2306706A1 FR7610341A FR7610341A FR2306706A1 FR 2306706 A1 FR2306706 A1 FR 2306706A1 FR 7610341 A FR7610341 A FR 7610341A FR 7610341 A FR7610341 A FR 7610341A FR 2306706 A1 FR2306706 A1 FR 2306706A1
Authority
FR
France
Prior art keywords
compsn
regulating agent
procedure
obtaining
intestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7610341A
Other languages
English (en)
French (fr)
Other versions
FR2306706B1 (OSRAM
Inventor
Nils Gosta Alvar Nilsson
Mats Oyvind Palsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco AB filed Critical Draco AB
Publication of FR2306706A1 publication Critical patent/FR2306706A1/fr
Application granted granted Critical
Publication of FR2306706B1 publication Critical patent/FR2306706B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7610341A 1975-04-09 1976-04-08 Agent regulateur intestinal et procede d'obtention Granted FR2306706A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7504053A SE7504053L (sv) 1975-04-09 1975-04-09 Svellmedel

Publications (2)

Publication Number Publication Date
FR2306706A1 true FR2306706A1 (fr) 1976-11-05
FR2306706B1 FR2306706B1 (OSRAM) 1979-03-16

Family

ID=20324217

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7610341A Granted FR2306706A1 (fr) 1975-04-09 1976-04-08 Agent regulateur intestinal et procede d'obtention

Country Status (12)

Country Link
JP (1) JPS51142546A (OSRAM)
AU (1) AU1275176A (OSRAM)
BE (1) BE840555A (OSRAM)
DE (1) DE2614455A1 (OSRAM)
DK (1) DK153276A (OSRAM)
FI (1) FI760960A7 (OSRAM)
FR (1) FR2306706A1 (OSRAM)
LU (1) LU74731A1 (OSRAM)
NL (1) NL7603360A (OSRAM)
NO (1) NO761087L (OSRAM)
NZ (1) NZ180551A (OSRAM)
SE (1) SE7504053L (OSRAM)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3332301A1 (de) * 1983-09-07 1985-03-21 Algina AG, Zug Metallsalze und metallmischsalze von polymeren, anionischen carbonsaeuren und/oder ihren schwefelsaeureestern, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung
EP0286085A1 (en) * 1987-04-08 1988-10-12 Ferrosan International A/S An antacid composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63165325A (ja) * 1986-12-27 1988-07-08 Snow Brand Milk Prod Co Ltd 整腸剤
CA2523339A1 (en) * 2003-04-25 2004-11-11 Kouki Bussan Yugenkaisha Agent for preventing and healing constipation

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3332301A1 (de) * 1983-09-07 1985-03-21 Algina AG, Zug Metallsalze und metallmischsalze von polymeren, anionischen carbonsaeuren und/oder ihren schwefelsaeureestern, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung
EP0286085A1 (en) * 1987-04-08 1988-10-12 Ferrosan International A/S An antacid composition
WO1988007862A1 (en) * 1987-04-08 1988-10-20 Farma Food A/S An antacid composition
US5068109A (en) * 1987-04-08 1991-11-26 Farma Food A/S Antacid composition

Also Published As

Publication number Publication date
DE2614455A1 (de) 1976-10-28
JPS51142546A (en) 1976-12-08
NO761087L (OSRAM) 1976-10-12
DK153276A (da) 1976-10-10
SE7504053L (sv) 1976-10-10
FI760960A7 (OSRAM) 1976-10-10
BE840555A (fr) 1976-10-11
NZ180551A (en) 1978-04-28
AU1275176A (en) 1977-10-20
LU74731A1 (OSRAM) 1977-02-04
FR2306706B1 (OSRAM) 1979-03-16
NL7603360A (nl) 1976-10-12

Similar Documents

Publication Publication Date Title
DE3760004D1 (en) Vinyl phenol derivatives, their preparation and their use
GB8817015D0 (en) Method of treatment
FR2306706A1 (fr) Agent regulateur intestinal et procede d'obtention
Korovitsky The part played by the ducts in the pancreatic secretion
Brunton Therapeutics of the Circulation
Blum et al. The thyroid cork: obstruction of the thoracic inlet due to retroclavicular goiter
Wright et al. Scleredema adultorum of Buschke with upper esophageal involvement.
GREENLEE et al. The effect of pancreatic fistula on gastric secretion
FR2417494A1 (fr) Nouvelles compositions analgesiques et antipyretiques contenant un derive de paracetamol
FR2352539A1 (fr) Procede et appareil pour la production d'un effet therapeutique dans le corps humain par pression en des endroits determines du corps
Henderson ACAPNIA AND SHOCK.—III. SHOCK AFTER LAPAROTOMY: ITS PREVENTION, PRODUCTION, AND RELIEF
Texter Ulcer Pain Mechanisms the Clinical Features of Active Peptic Ulcer Disease and Implications for Therapy
NO176347C (no) Fremgangsmåte for fremstilling av en farmasöytisk tablett inneholdende et tetracyklin
Van Dijk et al. 15-Hydroxy-eicosatetraenoic acid has minor anti-inflammatory properties in colitis
CHODOFF et al. Spontaneous perforation of common bile duct
DE69428797D1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
RU1805966C (ru) Вещество, обладающее противовоспалительным, биостимулирующим и общеукрепл ющим действием
Fadali et al. Enlarging the Lumen of the Carotid Sinus: An Experimental Treatment of Systemic Arterial Hypertension
Jones et al. Intussusception
Stone Perforation of the Gallbladder Occurring in the Late Stage of Pregnancy
SU1319854A1 (ru) Способ лечени больных первичным гипотиреозом
SU1130345A1 (ru) Способ лечени хронического уретропростатита
Kao et al. Respiratory sensitivity to carbon dioxide in cross-circulated dogs
Iwata et al. Misoprostol reverses the inhibition of gastric hyperemia and aggravation of gastric damage by tobacco cigarette smoke in the rat
Hart Flurbiprofen in the treatment of ankylosing spondylitis

Legal Events

Date Code Title Description
ST Notification of lapse